Multicenter Phase III Trial to Compare Radical Nephrectomy Plus Adjuvant Autologous Tumor Cell-Lysate Vaccine Versus Radical Nephrectomy Without Adjuvant Treatment for Renal Cell Carcinoma Stages pT2-3bN0-3M0: a 3-year Analysis

Reviewer: Thomas Dilling, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 20 de mayo del 2002

Translation for this article does not exist


Catherine and Finn
by OncoLink Editorial Team
December 01, 2015